JP2025508073A5 - - Google Patents
Info
- Publication number
- JP2025508073A5 JP2025508073A5 JP2024553443A JP2024553443A JP2025508073A5 JP 2025508073 A5 JP2025508073 A5 JP 2025508073A5 JP 2024553443 A JP2024553443 A JP 2024553443A JP 2024553443 A JP2024553443 A JP 2024553443A JP 2025508073 A5 JP2025508073 A5 JP 2025508073A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- amino acid
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2203269.2A GB202203269D0 (en) | 2022-03-09 | 2022-03-09 | TGF-Beta antibodies |
| GB2203269.2 | 2022-03-09 | ||
| PCT/EP2023/056082 WO2023170241A1 (en) | 2022-03-09 | 2023-03-09 | TGF-β ANTIBODIES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508073A JP2025508073A (ja) | 2025-03-21 |
| JP2025508073A5 true JP2025508073A5 (https=) | 2026-03-13 |
Family
ID=81175458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553443A Pending JP2025508073A (ja) | 2022-03-09 | 2023-03-09 | ＴＧＦ－β抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250188161A1 (https=) |
| EP (1) | EP4490186A1 (https=) |
| JP (1) | JP2025508073A (https=) |
| CN (1) | CN119173533A (https=) |
| AU (1) | AU2023229972A1 (https=) |
| CA (1) | CA3245104A1 (https=) |
| GB (1) | GB202203269D0 (https=) |
| IL (1) | IL315033A (https=) |
| WO (2) | WO2023170241A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| GB2461546B (en) | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
| RS61778B1 (sr) * | 2013-05-06 | 2021-06-30 | Scholar Rock Inc | Kompozicije i postupci za modulaciju faktora rasta |
| ES2860952T3 (es) | 2013-08-01 | 2021-10-05 | Univ Catholique Louvain | Proteína anti-garp y usos de la misma |
| EP3139957A4 (en) * | 2014-05-06 | 2018-04-25 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
| WO2016125017A1 (en) | 2015-02-03 | 2016-08-11 | Universite Catholique De Louvain | Anti-garp protein and uses thereof |
| AU2018387829B2 (en) | 2017-12-22 | 2024-12-19 | Argenx Bvba | Bispecific antigen binding construct |
-
2022
- 2022-03-09 GB GBGB2203269.2A patent/GB202203269D0/en not_active Ceased
-
2023
- 2023-03-09 US US18/845,158 patent/US20250188161A1/en active Pending
- 2023-03-09 EP EP23710740.4A patent/EP4490186A1/en active Pending
- 2023-03-09 WO PCT/EP2023/056082 patent/WO2023170241A1/en not_active Ceased
- 2023-03-09 IL IL315033A patent/IL315033A/en unknown
- 2023-03-09 WO PCT/EP2023/056083 patent/WO2023170242A1/en not_active Ceased
- 2023-03-09 JP JP2024553443A patent/JP2025508073A/ja active Pending
- 2023-03-09 CN CN202380038825.XA patent/CN119173533A/zh active Pending
- 2023-03-09 AU AU2023229972A patent/AU2023229972A1/en active Pending
- 2023-03-09 CA CA3245104A patent/CA3245104A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018509413A5 (https=) | ||
| CA3258002A1 (en) | FCRN BINDING MOLECULES AND METHODS OF USE | |
| JP2017501725A5 (https=) | ||
| CN113710229B (zh) | 用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物 | |
| US20230183344A1 (en) | T-cell bispecific binding proteins | |
| JP2021500391A5 (https=) | ||
| JP2020528768A5 (https=) | ||
| JP2022513434A5 (https=) | ||
| JP2025520420A5 (https=) | ||
| WO2019084064A4 (en) | Compositions and methods for the depletion of cd117+ cells | |
| JP2025504815A5 (https=) | ||
| KR20190039085A (ko) | 세포의 고갈을 위한 조성물 및 방법 | |
| CN112154156A (zh) | 抗cd38抗体的皮下给药 | |
| WO2019108863A4 (en) | Compositions and methods for the depletion of cd5+ cells | |
| JP2014509861A5 (https=) | ||
| JP2022521850A5 (https=) | ||
| WO2022002019A1 (zh) | 抗cd70抗体及其应用 | |
| JP2024530152A5 (https=) | ||
| WO2019108860A4 (en) | Compositions and methods for the depletion of cd2+ cells | |
| JP2025508073A5 (https=) | ||
| JP2021075580A5 (https=) | ||
| JP7714992B2 (ja) | 二重特異性抗体を有効成分として含む医薬組成物 | |
| US20250313644A1 (en) | Antibodies capable of specifically binding tl1a and use thereof | |
| NZ773089B2 (en) | Methods of reducing serum levels of fc-containing agents using fcrn antagonists | |
| NZ773089A (en) | Methods of reducing serum levels of fc-containing agents using fcrn antagonists |